Sponsor Pipeline

Newron Pharmaceuticals SPA Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07184619
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With…		 Trial sites expanded: 10 -> 15 locations
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07184619 Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With… Treatment-resistant Schizophrenia Recruiting
Disease Areas
Schizophrenia (1)
Get alerts when Newron Pharmaceuticals SPA's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free